The 24-month data from the entire cohort of the SUCCESS PTA study were presented by Thomas Zeller, MD, in a late-breaking clini ...
A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
We value keeping the Device Guide up to date.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
We value keeping the Device Guide up to date.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results